{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:01:43Z","timestamp":1775570503970,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,7]]},"DOI":"10.7759\/cureus.104810","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:45:18Z","timestamp":1772887518000},"source":"Crossref","is-referenced-by-count":1,"title":["Cholinergic Crisis Associated With Standard-Dose Pyridostigmine in a Hemodialysis Patient With Ocular Myasthenia Gravis and Marked Weight Loss"],"prefix":"10.7759","author":[{"given":"Kinoshita","family":"Junki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16229","article-title":"Generalized myasthenia gravis with acetylcholine receptor antibodies: a guidance for treatment","volume":"31","author":"Gilhus NE","year":"2024","unstructured":"Gilhus NE, Andersen H, Andersen LK, et al.. Generalized myasthenia gravis with acetylcholine receptor antibodies: a guidance for treatment. Eur J Neurol. 2024, 31:e16229. 10.1111\/ene.16229","journal-title":"Eur J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00604","article-title":"A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature","volume":"11","author":"Farrugia ME","year":"2020","unstructured":"Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature. Front Neurol. 2020, 11:604. 10.3389\/fneur.2020.00604","journal-title":"Front Neurol"},{"key":"ref3","article-title":"Cholinergic crisis","author":"Adeyinka A","year":"2025","unstructured":"Adeyinka A, Patel A, Kondamudi NP. Cholinergic crisis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.134","article-title":"Pyridostigmine kinetics with and without renal function","volume":"28","author":"Cronnelly R","year":"1980","unstructured":"Cronnelly R, Stanski DR, Miller RD, Sheiner LB. Pyridostigmine kinetics with and without renal function. Clin Pharmacol Ther. 1980, 28:78-81. 10.1038\/clpt.1980.134","journal-title":"Clin Pharmacol Ther"},{"key":"ref5","unstructured":"U.S. Food and Drug Administration. Pyridostigmine bromide tablets, USP. prescribing information. (2024). Accessed: February 15, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/020414Orig1s011corrected_lbl.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/nu17020221","article-title":"Malnutrition and frailty are associated with a higher risk of prolonged hospitalization and mortality in hospitalized older adults","volume":"17","author":"Tseng HK","year":"2025","unstructured":"Tseng HK, Cheng YJ, Yu HK, Chou KT, Pang CY, Hu GC. Malnutrition and frailty are associated with a higher risk of prolonged hospitalization and mortality in hospitalized older adults. Nutrients. 2025, 17:10.3390\/nu17020221","journal-title":"Nutrients"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05275-9","article-title":"Association between frailty and hypoproteinaemia in older patients: meta-analysis and systematic review","volume":"24","author":"Zhang L","year":"2024","unstructured":"Zhang L, Yang P, Yin F, Zhang J, Zhao B, Zhou J. Association between frailty and hypoproteinaemia in older patients: meta-analysis and systematic review. BMC Geriatr. 2024, 24:689. 10.1186\/s12877-024-05275-9","journal-title":"BMC Geriatr"},{"key":"ref8","article-title":"A case report of cholinergic crisis evolved from myasthenia gravis due to the tumor in trigone of bladder","volume":"37","author":"Liu J","year":"2016","unstructured":"Liu J, Feng X, Li M, Zhao T. A case report of cholinergic crisis evolved from myasthenia gravis due to the tumor in trigone of bladder. Neuro Endocrinol Lett. 2016, 37:411-3.","journal-title":"Neuro Endocrinol Lett"},{"key":"ref9","article-title":"An aged patient with dementia of cholinergic crisis by distigmine bromide","volume":"12","author":"Shinya H","year":"2009","unstructured":"Shinya H, Hakoda S, Kiuchi S. An aged patient with dementia of cholinergic crisis by distigmine bromide. J Jpn Soc Emerg Med. 2009, 12:453-57.","journal-title":"J Jpn Soc Emerg Med"},{"key":"ref10","article-title":"Distigmine- and rivastigmine-associated cholinergic crisis; fasting and pharmacokinetic considerations","volume":"18","author":"Sato S","year":"2015","unstructured":"Sato S, Yamashiro E, Kawamura S, et al.. Distigmine- and rivastigmine-associated cholinergic crisis; fasting and pharmacokinetic considerations. J Jpn Soc Emerg Med. 2015, 18:599-604.","journal-title":"J Jpn Soc Emerg Med"},{"key":"ref11","article-title":"Highlight: Cholinergic crisis due to distigmine bromide","volume":"18","year":"2011","unstructured":"Highlight. Cholinergic crisis due to distigmine bromide. J Jpn Soc Intensive Care Med. 2011, 18:176-7.","journal-title":"J Jpn Soc Intensive Care Med"},{"key":"ref12","article-title":"Acute poisoning of distigmine bromide","volume":"21","author":"Onodera M","year":"2008","unstructured":"Onodera M. Acute poisoning of distigmine bromide. Chudoku Kenkyu. 2008, 21:161-7.","journal-title":"Chudoku Kenkyu"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/00498259309059437","article-title":"Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine","volume":"23","author":"Eiermann B","year":"1993","unstructured":"Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993, 23:1263-75. 10.3109\/00498259309059437","journal-title":"Xenobiotica"},{"key":"ref14","unstructured":"National Center for Biotechnology Information (NCBI). PubChem compound summary for pyridostigmine (CID. (2026). https.\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Pyridostigmine."},{"key":"ref15","unstructured":"CKN. Dialysis of drugs. (2022). https.\/\/www.ckn.org.au\/system\/files\/2022%20Dialysis%20of%20Drugs%20Interative%20Final%20022222.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8010018","article-title":"Drug dosing considerations in critically ill patients receiving continuous renal replacement therapy","volume":"8","author":"Jang SM","year":"2020","unstructured":"Jang SM, Infante S, Abdi Pour A. Drug dosing considerations in critically ill patients receiving continuous renal replacement therapy. Pharmacy (Basel). 2020, 8:10.3390\/pharmacy8010018","journal-title":"Pharmacy (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000503453","article-title":"Sustainable effects of distigmine bromide on urinary bladder contractile function","volume":"105","author":"Obara K","year":"2020","unstructured":"Obara K, Tanaka Y. Sustainable effects of distigmine bromide on urinary bladder contractile function. Pharmacology. 2020, 105:135-44. 10.1159\/000503453","journal-title":"Pharmacology"},{"key":"ref18","article-title":"Establishing indicators for diagnosis of cholinergic crisis [Article in Japanese]","volume":"58","author":"Kariyone K","year":"2010","unstructured":"Kariyone K, Shimatani Y, Kurihara T, Nagao T, Fujita Y, Uesugi M. Establishing indicators for diagnosis of cholinergic crisis [Article in Japanese]. Rinsho Byori. 2010, 58:972-8.","journal-title":"Rinsho Byori"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468820-cholinergic-crisis-associated-with-standard-dose-pyridostigmine-in-a-hemodialysis-patient-with-ocular-myasthenia-gravis-and-marked-weight-loss","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:45:19Z","timestamp":1772887519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468820-cholinergic-crisis-associated-with-standard-dose-pyridostigmine-in-a-hemodialysis-patient-with-ocular-myasthenia-gravis-and-marked-weight-loss"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.104810","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,7]]}}}